Skip to main content

Modulation of the host flora

European Journal of Clinical Microbiology and Infectious Diseases volume 8, pages 1–7 (1989)Cite this article

Abstract

Modulation of the bacterial flora of patients with a high risk of acquiring an infection can be achieved in several ways. The approach used in the Leiden University Hospital is based on selective elimination of the aerobic bacteria in the oropharyngeal cavity and intestinal tract, leaving the anaerobic flora intact. This kind of selective modulation of the host flora has an advantage in that it does not affect the colonization resistance provided by bacterial antagonism, which prevents colonization by resistant but potentially pathogenic bacteria or fungi. The elimination of aerobic bacteria combined with nursing in protective isolation and consumption of food with few bacteria has led to a significant reduction of the incidence of major and fatal infections in patients during episodes of severe granulocytopenia. From these results it may be concluded that the objective of selective antibiotic modulation, namely, the prevention of infections, can be achieved with this approach.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Gorbach, S. L., Barza, M., Giuliano, M., Jacobus, N. V. Colonization resistance of the human intestinal microflora: testing the hypothesis in normal volunteers. European Journal of Clinical Microbial Infectious Diseases 1988, 7: 98–102.

    Google Scholar 

  2. van der Waaij, D., de Vries Berghuis, J. M., Lekkerkerk van der Wees, J. E. C. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. Journal of Hygiene 1971, 69: 405–411.

    PubMed  Google Scholar 

  3. van der Waaij, D., de Vries Berghuis, J. M., Lekkerkerk van der Wees, J. E. C. Colonization resistance of the digestive tract in mice during systemic antibiotic treatment. Journal of Hygiene 1972, 70: 605–610.

    PubMed  Google Scholar 

  4. van der Waaij, D., Berghuis-de Vries, J. M. Selective elimination ofEnterobacteriaceae species from the digestive tract in mice and monkeys. Journal of Hygiene 1974, 77: 205–211.

    Google Scholar 

  5. Bergeim, O., Hanszen, A. H., Pincussen, L., Weiss, E. Relation of volatile fatty acids and hydrogen sulphide to the intestinal flora. Journal of Infectious Diseases 1941, 69: 155–166.

    Google Scholar 

  6. Bohnhoff, M., Miller, C. P., Martin, W. R. Resistance of the mouse's intestinal tract to experimentalSalmonella infection. I. Journal of Experimental Medicine 1964, 120: 805–816.

    Article  Google Scholar 

  7. Guiot, H. F. L. Volatile fatty acids and the selective growth inhibition of aerobic bacteria in the gut of rats. In: Sasaki, S., Ozawa, A., Hashimoto, K. (ed.): Recent advances in germfree research. Tokai University Press, Tokyo, 1981, p. 219–221.

    Google Scholar 

  8. Guiot, H. F. L. Role of competition for substrate in bacterial antagonism in the intestines. Infection and Immunity 1982, 38: 887–892.

    PubMed  Google Scholar 

  9. Freter, R., Brickner, H., Fekete, J., Vickerman, M. M., Carey, K. E. Survival and implantation ofEscherichia coli in the intestinal tract. Infection and Immunity 1983, 39: 686–703.

    PubMed  Google Scholar 

  10. van der Waaij, D., Berghuis-de Vries, J. M., Lekkerkerk van der Wees, J. E. C. Colonization resistance of the digestive tract and the spread of bacteria to the lymphatic organs in mice. Journal of Hygiene 1972, 70: 335–342.

    PubMed  Google Scholar 

  11. Berg, R. D., Garlington, A. W. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infection and Immunity 1979, 23: 403–404.

    PubMed  Google Scholar 

  12. Steffen, E. K., Berg, R. D. Relationship between cecal population levels of indigenous bacteria and translocation to the mesenteric lymph nodes. Infection and Immunity 1983, 39: 1252–1259.

    PubMed  Google Scholar 

  13. Bodey, G. P., Buckley, M., Sathe, Y. S., Freireich, E. J. Quantitative relationship between circulating leukocytes and infections in patients with acute leukemia. Annals of Internal Medicine 1966, 64: 328–340.

    PubMed  Google Scholar 

  14. van der Meer, J. W. M., Boekhout, M., Alleman, M. Infectious episodes in severely granulocytopenic patients. Infection 1979, 7: 171–175.

    Article  PubMed  Google Scholar 

  15. Bodey, G. P., Rosenbaum, B. Effect of prophylactic measures of the microbial flora of patients in protected environment units. Medicine 1974, 53: 209–228.

    PubMed  Google Scholar 

  16. Bodey, G. P. Current status of prophylaxis of infection with protected environments. American Journal of Medicine 1984, 76: 678–684.

    Article  PubMed  Google Scholar 

  17. Schimpff, S. C. Infection prevention during profound granulocytopenia. New approaches to alimentary canal microbial suppression. Annals of Internal Medicine 1980, 93: 358–361.

    PubMed  Google Scholar 

  18. Ribas-Mundo, M., Graneda, A., Rozman, C. Evaluation of a protective environment in the management of granulocytopenic patients: a comparative study. Cancer 1981, 48: 419–424.

    PubMed  Google Scholar 

  19. Kurrle, E., Abt, C., Bhaduri, S., Heimpel, H., Krieger, D., Vanek, E., Kubanec, B. Possibilities and problems of protective isolation and antimicrobial decontamination in man. Zentralblatt für Bakteriologie 1979, (A) 7 (Supplement): 63–66.

    Google Scholar 

  20. Guiot, H. F. L., van der Meer, J. W. M., Fibbe, W. E., de Planque, M. M., Zwaan, F. E., Biemond, I. The effects of the intestinal microflora of selective decontamination in patients undergoing allogeneic bone marrow transplantation. Experimental Hematology 1985, (Supplement 17) 13: 108–109.

    Google Scholar 

  21. Guiot, H. F. L.: The effect of the intestinal microflora of selective decontaminated patients on the severity of acute graft-versus-host disease. In: Gnotobiology and its applications. Proceedings of the IXth International Symposium on Gnotobiology, Versailles, France. Edition Fondation Marcel Mérieux, Lyon,

  22. Petersen, F. B., Buckner, C. D., Clift, R. A., Nelsen, N., Counts, G. W., Meyers, J. D., Thomas, E. D. Infectious complication in patients undergoing marrow transplantation: a prospective randomized study of the additional effect of decontamination and laminar air flow isolation among patients receiving prophylactic systemic antibiotics. Scandinavian Journal of Infectious Diseases 1987, 19: 559–567.

    PubMed  Google Scholar 

  23. Guiot, H. F. L., van den Broek, P. J., van der Meer, J. W. M., van Furth, R. Selective antimicrobial modulation of the intestinal flora of patients with acute non-lymphocytic leukemia: a double-blind, placebo-controlled study. Journal of Infectious Diseases 1983, 147: 615–623.

    PubMed  Google Scholar 

  24. Guiot, H. F. L., van Furth, R. Partial antibiotic decontamination. British Medical Journal 1977, 1: 800–802.

    Google Scholar 

  25. Guiot, H. F. L., van der Meer, J. W. M., van Furth, R. Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria. Journal of Infectious Diseases 1981, 143: 644–654.

    PubMed  Google Scholar 

  26. van Furth, R., Nauta, E. H. Principles of antibiotic treatment. In: Elkerbout, F., Thomas, P., Zwaveling, A. (ed.): Cancer chemotherapy. Leiden University Press, Leiden, 1971, p. 387–394.

    Google Scholar 

  27. Bodey, G. P., Rodriquez, V., Chang, H., Narboni, G. Fever and infection in leukemic patients. Cancer 1978, 41: 1610–1621.

    PubMed  Google Scholar 

  28. McChesney, E. W., Froelich, E. J., Lesher, G. Y., Crain, A. V. R., Rosi, D. Absorption, excretion, and metabolism of a new antibacterial agent, nalidixic acid. Toxicology and Applied Pharmacology 1964, 6: 292–309.

    Article  Google Scholar 

  29. Guiot, H. F. L., Helmig-Schurter, A. V., van der Meer, J. W. M., van Furth, R. Selective antimicrobial modulation of the intestinal microbial flora for infection prevention in patients with hematologic malignancies. Evaluation of clinical efficacy and the value of surveillance cultures. Scandinavian Journal of Infectious Diseases 1986, 18: 153–160.

    PubMed  Google Scholar 

  30. van der Meer, J. W. M., Guiot, H. F. L., van den Broek, P. J., van Furth, R. Infections in bone marrow transplant recipients. Seminars in Hematology 1984, 21: 123–140.

    PubMed  Google Scholar 

  31. Willemze, R., Peters, W. G., van Hennik, M. B., Fibbe, W. E., Kootte, A. M. M., van Berkel, M., Lie, R., Rodenburg, C. J., Veltkamp, J. J. Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin's lymphoma. Scandinavian Journal of Haematology 1985, 34: 83–87.

    PubMed  Google Scholar 

  32. Peters, W. G., Willemze, R., Colly, L. P., Guiot, H. F. L. Side effects of intermediate- and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute leukaemia and non-Hodgkin's lymphoma. Netherlands Journal of Medicine 1987, 30: 64–74.

    PubMed  Google Scholar 

  33. Guiot, H. F. L., van den Broek, P. J., van der Meer, J. W. M., Peters, W. G., Willemze, R., van Furth, R. The association between streptococcal infection and interstitial pneumonia in chemotherapy and BMT. Bone Marrow Transplantation 1988, (Supplement 1) 3: 274.

    Google Scholar 

  34. Dekker, A. W., Rozenberg-Arska, M., Sixma, J. J., Verhoef, J. Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute non-lymphocytic leukemia. Annals of Internal Medicine 1981, 95: 555–559.

    PubMed  Google Scholar 

  35. Rozenberg-Arska, M., Dekker, A. W., Verhoef, J. Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria. Infection 1983, 11: 167–169.

    Article  PubMed  Google Scholar 

  36. Dekker, A. W., Rozenberg-Arska, M., Verhoef, J. Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfa methoxazole and colistin. Annals of Internal Medicine 1987, 106: 7–12.

    PubMed  Google Scholar 

  37. Piddock, L. J. V., Wijnands, W. J. A., Wise, R. Quinolone/ureidopenicillin cross-resistance. Lancet 1987, ii: 907.

    Article  Google Scholar 

  38. Sanders, C. C. Ciprofloxacin: in vitro activity, mechanism of action, and resistance. Reviews of Infectious Diseases 1988, 10: 516–527.

    PubMed  Google Scholar 

  39. Armstrong, D. Protected environments are discomforting and expensive and do not offer meaningful protection. American Journal of Medicine 1984, 76: 685–689.

    Article  PubMed  Google Scholar 

  40. Young, L. S. Antimicrobial prophylaxis in the neutropenic host: lessons of the past and perspectives for the future. European Journal of Clinical Microbiology and Infectious Diseases 1988, 7: 93–97.

    Google Scholar 

Download references

Author information

Affiliations

  1. Department of Infectious Diseases, University Hospital, Building 1, C5-P, P. O. Box 9600, 2300 RC, Leiden, The Netherlands

    R. van Furth & H. F. L. Guiot

Authors
  1. R. van Furth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. F. L. Guiot
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

van Furth, R., Guiot, H.F.L. Modulation of the host flora. Eur. J. Clin. Microbiol. Infect. Dis. 8, 1–7 (1989). https://doi.org/10.1007/BF01964112

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01964112

Keywords

  • High Risk
  • Internal Medicine
  • Pathogenic Bacterium
  • Intestinal Tract
  • Aerobic Bacterium